IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $77,000 | +24.2% | 10,713 | +1.6% | 0.00% | – |
Q4 2020 | $62,000 | +100.0% | 10,548 | -8.2% | 0.00% | – |
Q3 2020 | $31,000 | -93.6% | 11,493 | -89.3% | 0.00% | -100.0% |
Q2 2020 | $485,000 | +2594.4% | 107,646 | +298.3% | 0.00% | – |
Q3 2019 | $18,000 | -21.7% | 27,027 | +11.5% | 0.00% | – |
Q2 2019 | $23,000 | -37.8% | 24,238 | +135.6% | 0.00% | – |
Q4 2018 | $37,000 | -64.4% | 10,288 | -5.2% | 0.00% | -100.0% |
Q2 2018 | $104,000 | -12.6% | 10,857 | -4.2% | 0.00% | 0.0% |
Q1 2018 | $119,000 | +60.8% | 11,334 | -6.3% | 0.00% | 0.0% |
Q4 2017 | $74,000 | -28.2% | 12,097 | -8.5% | 0.00% | 0.0% |
Q3 2017 | $103,000 | -19.5% | 13,220 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $128,000 | +93.9% | 17,184 | -0.1% | 0.00% | 0.0% |
Q1 2017 | $66,000 | +288.2% | 17,202 | +23.6% | 0.00% | – |
Q4 2016 | $17,000 | -62.2% | 13,913 | -28.5% | 0.00% | -100.0% |
Q3 2016 | $45,000 | -70.0% | 19,461 | +12.6% | 0.00% | – |
Q1 2016 | $150,000 | -38.0% | 17,284 | -4.7% | 0.00% | -100.0% |
Q4 2015 | $242,000 | – | 18,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |